ARCHIVES

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007

ASCO Lists Top 11 Advances In Clinical Cancer Research

December 30, 2005

Tim Lee Carter Named Chairman Of NCAB; Five Others Appointed

June 11, 1982

Sanofi Responds to Criticism From Oncologists

November 8, 2012

Sequestration Delayed For Two Months While Congress Debates Debt and Budgets

January 4, 2013

Controversial Toxicology Protocol Is “Getting The Information We Need;” Additionally Revision Made

March 2, 1984